Charles Schwab
VERA icon

Charles Schwab’s Vera Therapeutics VERA Stock Holding History

Charles Schwab’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.4M Buy
545,013
+20,451
+4% +$762K ﹤0.01% 1743
2026
Q1 		$21.1M Buy
524,562
+5,704
+1% +$246K ﹤0.01% 1719
2025
Q4 		$26.3M Buy
518,858
+53,049
+11% +$1.88M ﹤0.01% 1574
2025
Q3 		$13.5M Buy
465,809
+21,353
+5% +$494K ﹤0.01% 1956
2025
Q2 		$10.5M Buy
444,456
+19,516
+5% +$439K ﹤0.01% 1990
2025
Q1 		$10.2M Sell
424,940
-5,725
-1% -$184K ﹤0.01% 1943
2024
Q4 		$18.2M Buy
430,665
+68,860
+19% +$3.05M ﹤0.01% 1749
2024
Q3 		$16M Buy
361,805
+10,717
+3% +$407K ﹤0.01% 1814
2024
Q2 		$12.7M Buy
351,088
+12,663
+4% +$502K ﹤0.01% 1920
2024
Q1 		$14.6M Buy
338,425
+60,469
+22% +$2.15M ﹤0.01% 1791
2023
Q4 		$4.27M Buy
277,956
+10,952
+4% +$139K ﹤0.01% 2377
2023
Q3 		$3.66M Buy
267,004
+176,473
+195% +$3.03M ﹤0.01% 2395
2023
Q2 		$1.45M Buy
90,531
+29,112
+47% +$263K ﹤0.01% 2649
2023
Q1 		$477K Buy
61,419
+22,560
+58% +$174K ﹤0.01% 2966
2022
Q4 		$752K Buy
38,859
+969
+3% +$17.5K ﹤0.01% 2879
2022
Q3 		$808K Buy
37,890
+3,199
+9% +$59.9K ﹤0.01% 2855
2022
Q2 		$473K Sell
34,691
-52
-0.1% -$907 ﹤0.01% 3099
2022
Q1 		$817K Buy
34,743
+11,251
+48% +$242K ﹤0.01% 2931
2021
Q4 		$628K Buy
23,492
+6,544
+39% +$145K ﹤0.01% 3079
2021
Q3 		$295K Buy
+16,948
New +$303K ﹤0.01% 3272

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Charles Schwab's VERA Position: Q2 2026 in Review

Charles Schwab increased its Vera Therapeutics (VERA) stake by 3.9% in Q2 2026, buying an estimated $762K and bringing the position to 545,013 shares worth $23.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1743.

Charles Schwab first reported a position in VERA in Q3 2021 and has held it in 20 quarters since. The position peaked at $26.3M in Q4 2025. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Charles Schwab held 545,013 shares of Vera Therapeutics worth $23.4M as of Q2 2026.
  • Charles Schwab bought 20,451 Vera Therapeutics shares in Q2 2026, an estimated $762K.
  • Vera Therapeutics made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #1743 holding.
  • Charles Schwab first reported a position in Vera Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • Charles Schwab's Vera Therapeutics position peaked at $26.3M in Q4 2025.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.